Angiotensin II Receptor Blocker Associated With Less Outcome Risk in Patients With Acute Kidney Disease

Objective: The aim of this study was to explore the respective use of angiotensin-converting-enzyme inhibitors (ACEis) or angiotensin receptor blockers (ARBs) on the outcomes of patients who could be weaned from dialysis-requiring acute kidney injury (AKI-D). Methods: This case–control study enrolle...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Vin-Cent, Lin, Yu-Feng, Teng, Nai-Chi, Yang, Shao-Yu, Chou, Nai-Kuan, Tsao, Chun-Hao, Chen, Yung-Ming, Chueh, Jeff S, Chen, Likwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065477/
https://www.ncbi.nlm.nih.gov/pubmed/35517809
http://dx.doi.org/10.3389/fphar.2022.714658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065477/
https://www.ncbi.nlm.nih.gov/pubmed/35517809
http://dx.doi.org/10.3389/fphar.2022.714658

Ejemplares similares